Quantum BioPharma Ltd. is trading 5% up at $4.47 as shares rebound from last week’s steep slide triggered by an FDA clinical hold on its lead multiple sclerosis candidate.
- The stock is bouncing after a multi-session selloff following the regulatory setback.
- Traders continue to show speculative interest as they reassess the impact of the clinical hold against prior downside.